非酒精性脂肪肝模型小鼠肝中脂肪酸组成分析

doi:10.3864/j.issn.0578-1752.2011.17.019

摘要/Abstract

摘要： 【目的】通过检测非酒精性脂肪性肝病（NAFLD）模型小鼠肝中脂肪酸的含量，分析肝脏中脂肪酸组成与NAFLD之间的关系。【方法】采用连续6周饲喂高脂饲料并结合每周皮下注射2次CCl4的方法诱导C57BL/6J小鼠的NAFLD。小鼠肝脏中脂肪酸经乙醚提取和BF3/甲醇溶液衍生化处理后，采用气相色谱-质谱 (GC-MS) 选择离子方式进行检测。样品中脂肪酸通过检索质谱数据库和脂肪酸标准品的保留时间进行定性分析，采用外标法进行定量分析。【结果】病理学检查表明成功诱导C57BL/6J小鼠的NAFLD。与对照组相比，试验组小鼠肝中C14:0、C16:0、C18:0和C20:3含量显著升高 (P＜0.01)，C15:0、C18:1、C18:2和C18:3 (n-3)含量显著降低 (P＜0.01)，饱和脂肪酸（SFA）含量显著增加(P＜0.01)，其余类别的脂肪酸均显著降低 (P＜0.01)。n-6 和 n-3 多不饱和脂肪酸（PUFA）的产物/前体比值显著升高(P＜0.01)，n-6/n-3 PUFA [C20:4/(C20:5+C22:6)]的比值显著降低 (P＜0.01)。【结论】NAFLD小鼠肝脏中SFA含量增加、不饱和脂肪酸含量减少以及 n-6 PUFA与 n-3 PUFA代谢紊乱不仅是NAFLD产生的效果，也是促进NAFLD发展的因素。

关键词: 脂肪酸, 非酒精性脂肪性肝病, 小鼠, 气相色谱-质谱

Abstract: 【Objective】 The aim of this study was to determine the liver fatty acid composition of an experimental mouse model of NAFLD induced by high-fat feed and CCl4 and to assess the association between the change of liver fatty acids content and NAFLD. 【Method】C57BL/6J mice were given high-fat feed for six consecutive weeks to develop experimental NAFLD. Meanwhile, these mice were given subcutaneous injections of a 40% CCl4-vegetable oil mixture twice per week. Fatty acids in mice liver were extracted with diethyl and derived by BF3/methanol, then analyzed by gas chromatography-mass spectrometry (GC-MS) in selected ion monitoring. Qualitative analysis of fatty acids in mice liver was carried out according to the retrieval mass spectrometry database and the retention time of fatty acid standard. Quantitative analysis was determined by external standard method. 【Result】Pathological examination showed that NAFLD of C57BL/6J mice was successfully induced. Compared with the control group, high-fat feed and CCl4 led to significant increases in C14:0, C16:0, C18:0 and C20:3 (P＜0.01), and decreases in C15:0, C18:1, C18:2 and C18:3 (n-3) (P＜0.01) in the mouse liver. The treatment also led to an increase in saturated fatty acids (SFA) and decreases in other types fatty acids. An increase in the ratio of product/precursor n-6 (C20:4/C18:2) and n-3 [(C20:5+C22:6)/C18:3 (n-3)] and a decrease in the ratio of n-6/n-3 [C20:4/(C20:5+C22:6)] were also observed.【Conclusion】An increase of SFA, a decrease of unsaturated fatty acids (UFA), and metabolic disturbance of n-6 polyunsaturated fatty acids (PUFA) and n-3 PUFA in the liver of mice with NAFLD induced by high-fat feed and CCl4 were not only the results of NAFLD, but also the stimulating factors for the development of NAFLD.

Key words: Fatty acids, non-alcoholic fatty liver disease, mice, gas chromatography-mass spectrometry

王新, 曹玉珍, 郭桂芳, 李睿, 张秀英. 非酒精性脂肪肝模型小鼠肝中脂肪酸组成分析[J]. 中国农业科学, 2011, 44(17): 3658-3665.

WANG Xin, CAO Yu-Zhen, GUO Gui-Fang, LI Rui, ZHANG Xiu-Ying. Analysis of Fatty Acids Composition in the Liver of Mice with Non-alcoholic Fatty Liver Disease[J]. Scientia Agricultura Sinica, 2011, 44(17): 3658-3665.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.chinaagrisci.com/CN/10.3864/j.issn.0578-1752.2011.17.019

https://www.chinaagrisci.com/CN/Y2011/V44/I17/3658

参考文献

[1]Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003, 37(4): 917-923.

[2]Erickson S K. Nonalcoholic fatty liver disease. Journal of Lipid Research, 2009, 50: S412-S416.

[3]钱林,胡小宣. 非酒精性脂肪肝分子发病机制的研究进展. 世界华人消化杂志, 2008, 16(25): 2848-2852.

Qian L, Hu X X. Advance in the molecular pathogenesis of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 2008, 16(25): 2848-2852. (in Chinese)

[4]Li Z Z, Berk M, McIntyre T M, Gores G J, Feldstein A E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology, 2008, 47(5): 1495-1503.

[5]Joshi-Barve S, Barve S S, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain C J. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology, 2007, 46(3): 823-830.

[6]Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R, Nakamuta M. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. International Journal of Molecular Medicine, 2007, 20(3): 351-358.

[7]阎明, 孟繁立, 吕瑞娟, 贾晓青. 四氯化碳性脂肪肝血清游离脂肪酸谱变化. 中国病理生理杂志, 2004, 20(8): 1485-1488.

Yan M, Meng F L, Lv R F, Jia X Q. Alteration of serum free fatty acids during the carbon tetrachloride- induced fatty liver in rats. Chinese Journal of Pathophysiology, 2004, 20(8): 1485-1488. (in Chinese)

[8]DeAlmeida I T, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo M E. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clinical Nutrition, 2002, 21(3): 219-223.

[9]Dixon J B, Bhathal P S, Hughes N R, O’Brien P E. Nonalcoholic fatty liver disease：Improvement in liver histological analysis with weight loss. Hepatology, 2004, 39(6): 1647-1654．

[10]Brunt E M, Tiniakos D G. Histopathology of nonalcoholic fatty liver disease. World Journal of Gastroenterology，2010, 16(42): 5286-5296.

[11]Schwimmer J B, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork N J, Lavine J E. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology, 2005, 42(3): 641-649.

[12]Soares M, Lopez-Bote C J. Effects of dietary lecithin and fat unsaturation on nutrient utilisation in weaned piglets. Animal Feed Science and Technology, 2002, 95(3-4): 169-177.

[13]Choi J S, Kim H, Jung M H, Hong S, Song J. Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Molecular Nutrition & Food Research, 2010, 54(7): 1004-1013.

[14]Kennedy A, Martinez K, Chuang C C, LaPoint K, McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: Mechanisms of action and implications. The Journal of Nutrition, 2009, 139(1): 1-4.

[15]Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of haloalkane: carbon tetrachloride as a toxicological model. Critical Reviews in Toxicology, 2003, 33(2): 105-136.

[16]Yao D, Shi W, Gou Y, Zhou X, Yee A T, Zhou Y, Liu Z. Fatty acid-mediated intracellular iron translocation: a synergistic mechanism of oxidative injury. Free Radical Biology & Medicine, 2005, 39(10): 1385-1398.

[17]Barreyro FJ, Kobayashi S, Bronk S F, Werneburg N W, Malhi H, Gores G J. Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. Journal of Biolological Chemistry, 2007, 282(37): 27141-27154.

[18]Puri P, Baillie R A, Wiest M M, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos M J, Sanyal A J. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology, 2007, 46(4): 1081-1090.

[19]Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee G S, Ng R K, Turner S M, Badger T M, Pitas R E, Maher J J. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with suppression of SCD-1. Journal Lipid Research, 2006, 47: 2280-2290.

[20]杨丽丽, 柳涛, 王淼, 邢练军, 季光, 郑培永. 氧化应激与非酒精性脂肪性肝病研究进展. 世界华人消化杂志, 2009, 17(9): 896-900.

Yang L L, Liu T, Wang M, Xing L J, Ji G, Zheng P Y. Progress in research of oxidative stress and nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 2009, 17(9): 896-900. (in Chinese)

[21]陆金来, 陈金联, 陈明祥, 洪静, 陈维雄, 朱金水, 陈尼维. 肝脏脂肪酸在高脂饮食大鼠非酒精性脂肪性肝病模型中的代谢. 世界华人消化杂志, 2008, 16(16): 1728-1733.

Lu J L, Chen J L, Chen M X, Hong J, Chen W W, Zhu J S, Chen N W. Fatty acids metabolic profile in high fat diet-induced nonalcoholic fatty liver disease in rats. World Chinese Journal of Digestology, 2008, 16(16): 1728-1733. (in Chinese)

[22]Buang Y, Cha J Y, Nagao K, Wang Y M, Inoue N, Yanagita T. Alleviation of fatty liver by alpha-linolenic acid. Journal Nutritional Science and Vitaminology, 2004, 50(4): 272-276.

[23]Videla L A, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radical Biology and Medicine, 2004, 37(9): 1499-1507.

[24]Clore J N, Stillman J S, Li J, O'Keefe S J, Levy J R. Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans. Americal Journal of Physiology- Endocrinology and Metabolism, 2004, 287(2): E358-E365.

[25]Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Science, 2009, 116(1): 1-16.

[26]Capanni M, Calella F, Biagini M R, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcohoic fatty liver disease: a pilot study. Alimentary Pharmacology & Therapeutics, 2006, 23(8): 1143-1151.

[27]Levy J R, Clore J N, Stevens W. Dietary n-3 polyunsaturated fatty acid decrease hepatic triglycerides in fischer 344 rats. Hepatology, 2004, 39(3): 608-616.

[28]El-Badry A M, Graf R, Clavien P A. Omega 3-Omega 6: What is right for the liver? Hepatology, 2007, 47: 718-725.

[29]Chapkin R S, Davidson L A, Ly L, Weeks B R, Lupton J R, McMurray D N. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. Journal Nutrition, 2007, 137: 200-204.

[30]Yonezawa Y, Hada T, Uryu K, Tsuzuki T, Eitsuka T, Miyazawa T, Murakami-Nakai C, Yoshida H, Mizushina Y. Inhibitory effect of conjugated eicosapentaenoic acid on mammalian DNA polymerase and topoisomerase activities and human cancer cell proliferation. Biochemical Pharmacology, 2005, 70: 453-460.

[31]Larter C Z, Yeh M M, Haigh W G, Williams J, Brown S, Bell-Anderson K S, Lee S P, Farrell G C. Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways. Journal of Hepatology, 2008, 48: 638-647.

[32]Araya J, Rodrigo R, Videla L A, Thielemann L, Orellana M, Pettinelli P, Poniachik J. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clinical Science, 2004, 106(6): 635-643.

[33]Tallman D L, Taylor C G. Effects of dietary fat and zinc on adiposity, serum leptin and adipose fatty acid composition in C57BL/6J mice. Journal of Nutritional Biochemistry, 2003, 14(1): 17-23.